To understand whether GPS1 plays a role in regulating TP53 activity, we analyzed the correlation between TP53 mutation status and GPS1 expression, and our results showed that GPS1 levels were higher in TP53-mutant breast cancers compared to TP53-free breast cancers (P < 0.05, Fig. 3B). This evidence concerns the gene GPS1 and breast carcinoma.